通信作者:张良明(1962-),男,博士,主任医师,硕士生导师,主要从事肿瘤内科临床工作。
中晚期非小细胞肺癌患者外周血Treg、Th17细胞化疗前后的变化及临床意义
赵丽丽1,2,张良明3
(1.滨州医学院,山东 烟台 264000;2.巨野县人民医院肿瘤科,
山东 巨野 274900;3.烟台毓璜顶医院肿瘤科,山东 烟台 264000)
[摘要]目的分析中晚期非小细胞肺癌患者化疗前后外周血中Treg细胞和Th17细胞比例变化及临床意义。方法收集51例中晚期非小细胞肺癌患者(观察组)化疗前后及47例健康对照组外周血标本,应用流式细胞术检测Treg细胞和Th17细胞所占CD4+ T细胞的比例,观察Treg和Th17细胞比例在化疗前后的变化及其相关性。结果化疗后缓解组外周血中Th17及Treg细胞比例较化疗前降低(P<0.05),Treg细胞仍高于对照组(P<0.05),Th17细胞比例稍高于对照组(P>0.05)。非缓解组2种细胞的比例较化疗前增高(P<0.05),并明显高于对照组(P<0.05)。无论是化疗前,还是化疗后,非小细胞肺癌患者外周血中Th17与Treg细胞之间均存在正相关关系(r=0.589、0.657,P<0.05)。结论化疗能够降低非小细胞肺癌患者外周血中Th17及Treg细胞比例,对肿瘤免疫功能具有积极意义。
[关键词]非小细胞肺癌;Th17细胞;Treg细胞;肿瘤免疫功能
作者简介:赵丽丽(1978-),女,硕士在读,主治医师,主要从事肿瘤内科临床工作。E|mail:zllmmxb@163.com
DOI:10.3969/j.issn.1673-5412.2015.04.006
[中图分类号]R734.2;R730.53
收稿日期:(2015-03-31)
Changes of Th17 and Treg Cells in the Peripheral Blood of Patients with Advanced Non|small Cell Lung Cancer Before and After Chemotherapy
Zhao Lili1,2,Zhang Liangming3
(1.BinzhouMedicalCollege,Yantai264000,China;2.DepartmentofOncology,JuyePeople’sHospital,Heze274900,China;3.DepartmentofOncology,YantaiYuhuangdingHospital,Yantai264000,China)
Abstract[]ObjectiveTo explore the changes of Th17 and Treg cells in the peripheral blood of patients with advanced non|small cell lung cancer before and after chemotherapy,and to observe the clinical significance.MethodsFlow cytometry was used to detect the proportion of Th17 and Treg cells in the peripheral blood of 51 patients with advanced non|small cell lung cancer (the observation group) before and after chemotherapy and 47 healthy volunteers (the control group),and the correlation was observed too.ResultsThe proportion of Th17 and Treg cells of the remission group after chemotherapy were all significantly lower than before chemotherapy (P<0.05).Compared with the control group,the proportion of Th17 cells of the remission group did not change significantly (P>0.05),but the proportion of Treg cells of the remission group was higher significantly (P<0.05).The proportion of Th17 and Treg cells of the non|remission group after chemotherapy were all significantly higher than before chemotherapy (P<0.05),and were higher than those of the control group (P<0.05).The proportion of Th17 cells were positively related to the proportion of Treg cells in the peripheral blood of patients with advanced non|small cell lung cancer before and after chemotherapy (r=0.589,0.657; P<0.05).ConclusionChemotherapy can reduce the proportion of Th17 cells and Treg cells in the peripheral blood of patients with advanced non|small cell lung cancer,and has the positive significance for tumor immune function.
[Key words]non|small cell lung cancer; Th17 cells; Treg cells; tumor immune
Treg细胞和Th17细胞是CD4+辅助性T细胞的2个亚型,关于这2种细胞在感染、自身免疫性疾病、移植排斥反应中的作用有很多报道[1-3],有学者发现Treg、Th17细胞在多种肿瘤患者的外周血中异常表达,但关于肺癌化疗前后2种细胞的变化情况少有报道。本研究采用流式细胞仪对中晚期非小细胞肺癌患者化疗前后外周血中的Th17细胞和Treg细胞比例进行检测并分析,旨在探究其与肿瘤进展的关系以及2种细胞之间的相关性,现将结果报道如下。
1资料与方法
1.1研究对象选取2012年10月至2014年5月巨野县人民医院收治的经病理确诊的中晚期非小细胞肺癌患者51例作为观察组,其中男33例,女18例;……